Cargando…
Berberine suppresses advanced glycation end products‐associated diabetic retinopathy in hyperglycemic mice
Autores principales: | Wang, Ning, Wang, Leilei, Zhang, Cheng, Tan, Hor‐Yue, Zhang, Yinjian, Feng, Yibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567055/ https://www.ncbi.nlm.nih.gov/pubmed/34841704 http://dx.doi.org/10.1002/ctm2.569 |
Ejemplares similares
-
Involvement of advanced glycation end‐products in ‘hyperglycemic memory’
por: Nishikawa, Takeshi, et al.
Publicado: (2015) -
Berberine improves insulin-induced diabetic retinopathy through exclusively suppressing Akt/mTOR-mediated HIF-1α/VEGF activation in retina endothelial cells
por: Wang, Ning, et al.
Publicado: (2021) -
Modulation of gut microbiota mediates berberine‐induced expansion of immuno‐suppressive cells to against alcoholic liver disease
por: Li, Sha, et al.
Publicado: (2020) -
Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells
por: Wang, Ning, et al.
Publicado: (2016) -
Advanced glycation end products in diabetic retinopathy and phytochemical therapy
por: Kang, Qingzheng, et al.
Publicado: (2022)